ID

42476

Description

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 19.03.2021 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS, a multi-center cohort study, has been created to get more in-depth knowledge about the epidemiology and clinical course of patients infected with SARS-CoV-2. Initiated by the ESCMID Emerging Infections Task Force (EITaF) and the German Infectious Disease Society, and supported by all German Centers for Health Research (DZG), LEOSS has developed into an international network of contributors. Via an integrative research approach with anonymous recruitment and collection of routine data in an open science context, LEOSS is building a uniform clinical dataset and providing real-time analyses. For more information feel free to explore https://leoss.net/. Please note that only cases with known outcome are collected! Baseline / diagnosis is defined as the day the sample of the first positive SARS-CoV-2 result was taken. Criteria of the Uncomplicated Phase: Asymptomatic OR Symptoms of upper respiratory tract infection and/or Nausea, emesis, diarrhea and/or Fever Remember: The Uncomplicated Phase ends, if a previously febrile patient has no fever anymore and has completed 14 days of follow-up without entering Complicated or Critical Phase; then move to Recovery Phase. Also, as soon as one of the criteria of the Complicated or Critical Phase are fulfilled, Uncomplicated Phase ends; move over to there. If the patient has died, the phase ends with the death of the patient. If the patient has died, do not report terminal values, e.g. those recorded after switching off life-support or heart rate "0" after death of the patient. Criteria of the Complicated Phase: * Need for oxygen supplementation (In patients with prior oxygen home therapy, clinically meaningful increase in need for oxygenation.) * paO2 at room air < 70 mmHg * SO2 at room air < 90 % * GOT or GPT > 5x ULN * New cardiac arrhythmia * New pericardial effusion >1cm * New heart failure with pulmonary edema, congestive hepatopathy or peripheral edema Remember: The Complicated Phase ends, if none of the criteria for the Complicated Phase is fulfilled anymore AND the patient is free of fever; then move to Recovery Phase. Also, as soon as one of the criteria of the Critical Phase are fulfilled, Complicated Phase ends; move over to Critical Phase. If the patient has died, the phase ends with the death of the patient. If the patient has died, do not report terminal values, e.g. those recorded after switching off life-support or heart rate "0" after death of the patient. Criteria of the Critical Phase: * Need for catecholamines * Life-threatening cardiac arrhythmia * Mechanical ventilation (invasive or non-invasive) * Liver failure with Quick< 50% * qSOFA >= 2 * Renal failure in need of dialysis Remember: The Critical Phase ends as soon as none of the criteria for the Critical Phase is fulfilled anymore AND the patient is free of fever. If the patient has died, it ends with the death of the patient. If the patient has died, do not report terminal values, i.e. those recorded after turning off life-support or heart rate "0" after death of the patient. Criteria of the Recovery Phase: *Improvement by at least one phase, i.e. Critical to Complicated or Complicated to Uncomplicated * Defervescence Remember: Uncomplicated asymptomatic patients enter recovery phase after 14 days of observation without disease progression No further progression or re-hospitalization If a text field can't be filled out, note 'ND' (for not determined).

Link

https://leoss.net

Keywords

  1. 7/2/21 7/2/21 - Sarah Riepenhausen
  2. 7/15/21 7/15/21 - Sarah Riepenhausen
  3. 7/16/21 7/16/21 - Sarah Riepenhausen
Copyright Holder

LEOSS

Uploaded on

July 16, 2021

DOI

10.21961/mdm:42476

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

Cardiovascular sub-cohort

Drugs at the time of SARS-CoV-2 detection
Description

Drugs at the time of SARS-CoV-2 detection

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C1442488
Aldosteron antagonist (spironolacton, eplerenon)
Description

Aldosteron antagonist at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0002007
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C0037982
UMLS CUI [2,2]
C1442488
UMLS CUI [3,1]
C0961485
UMLS CUI [3,2]
C1442488
Other diuretics (HCT, furosemide etc.)
Description

Other diuretics (HCT, furosemide etc.) at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0012798
UMLS CUI [1,3]
C1442488
UMLS CUI [2,1]
C0016860
UMLS CUI [2,2]
C1442488
UMLS CUI [3,1]
C0020261
UMLS CUI [3,2]
C1442488
Platelet inhibition (ASS, clopidogrel, etc.)
Description

Platelet inhibition (ASS, clopidogrel, etc.) at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0919737
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C0004057
UMLS CUI [2,2]
C1442488
UMLS CUI [3,1]
C0070166
UMLS CUI [3,2]
C1442488
Oral anticoagulants
Description

Oral anticoagulants at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0354604
UMLS CUI [1,2]
C1442488
Calcium channel blocker (amlodipin, nifedipin, other drugs ending on -dipin)
Description

Calcium channel blocker (amlodipin, nifedipin, other drugs ending on -dipin) at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0006684
UMLS CUI [1,2]
C1442488
UMLS CUI [2,1]
C0028066
UMLS CUI [2,2]
C1442488
UMLS CUI [3,1]
C0051696
UMLS CUI [3,2]
C1442488
UMLS CUI [4,1]
C0205394
UMLS CUI [4,2]
C0006684
UMLS CUI [4,3]
C1442488
Other antihypertensive therapy
Description

Other antihypertensive therapy at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C0585941
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C1442488
Heart failure
Description

Heart failure

Alias
UMLS CUI-1
C0018801
Stage of heart failure at Baseline (NYHA classification)
Description

NYHA classification at Baseline

Data type

integer

Alias
UMLS CUI [1,1]
C1275491
UMLS CUI [1,2]
C0018801
UMLS CUI [1,3]
C1442488
First diagnosis of heart failure: Indicate the years passed
Description

First diagnosis of heart failure: duration

Data type

integer

Alias
UMLS CUI [1,1]
C0011900
UMLS CUI [1,2]
C0205435
UMLS CUI [1,3]
C0018801
UMLS CUI [1,4]
C0449238
Is data entry for this section finished?
Description

Is data entry for this section finished?

Alias
UMLS CUI-1
C4684556
UMLS CUI-2
C1828479
UMLS CUI-3
C0205197
Is data entry for this section finished?
Description

Is data entry for this section finished?

Data type

integer

Alias
UMLS CUI [1,1]
C4684556
UMLS CUI [1,2]
C1828479
UMLS CUI [1,3]
C0205197

Similar models

Cardiovascular sub-cohort

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Drugs at the time of SARS-CoV-2 detection
C0013227 (UMLS CUI-1)
C1442488 (UMLS CUI-2)
Item
Aldosteron antagonist (spironolacton, eplerenon)
integer
C0002007 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C0037982 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0961485 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
Code List
Aldosteron antagonist (spironolacton, eplerenon)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other diuretics (HCT, furosemide etc.)
integer
C0205394 (UMLS CUI [1,1])
C0012798 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
C0016860 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0020261 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
Code List
Other diuretics (HCT, furosemide etc.)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Platelet inhibition (ASS, clopidogrel, etc.)
integer
C0919737 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0070166 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
Code List
Platelet inhibition (ASS, clopidogrel, etc.)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Oral anticoagulants
integer
C0354604 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
Code List
Oral anticoagulants
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Calcium channel blocker (amlodipin, nifedipin, other drugs ending on -dipin)
integer
C0006684 (UMLS CUI [1,1])
C1442488 (UMLS CUI [1,2])
C0028066 (UMLS CUI [2,1])
C1442488 (UMLS CUI [2,2])
C0051696 (UMLS CUI [3,1])
C1442488 (UMLS CUI [3,2])
C0205394 (UMLS CUI [4,1])
C0006684 (UMLS CUI [4,2])
C1442488 (UMLS CUI [4,3])
Code List
Calcium channel blocker (amlodipin, nifedipin, other drugs ending on -dipin)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other antihypertensive therapy
integer
C0585941 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Code List
Other antihypertensive therapy
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Heart failure
C0018801 (UMLS CUI-1)
Item
Stage of heart failure at Baseline (NYHA classification)
integer
C1275491 (UMLS CUI [1,1])
C0018801 (UMLS CUI [1,2])
C1442488 (UMLS CUI [1,3])
Code List
Stage of heart failure at Baseline (NYHA classification)
CL Item
NYHA I: No symptoms and no limitation in ordinary physical activity, e.g. shortness of breath when walking, climbing stairs etc. (1)
CL Item
NYHA II: Mild symptoms (mild shortness of breath and/or angina) and slight limitation during ordinary activity. (2)
CL Item
NYHA III: Marked limitation in activity due to symptoms, even during less-than-ordinary activity, e.g. walking short distances (20-100 m).Comfortable only at rest. (3)
CL Item
NYHA IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients. (4)
CL Item
Unknown (5)
Item
First diagnosis of heart failure: Indicate the years passed
integer
C0011900 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Code List
First diagnosis of heart failure: Indicate the years passed
CL Item
<1 year (1)
CL Item
1-5 years (2)
CL Item
>5 years (3)
CL Item
Unknown (4)
Item Group
Is data entry for this section finished?
C4684556 (UMLS CUI-1)
C1828479 (UMLS CUI-2)
C0205197 (UMLS CUI-3)
Item
Is data entry for this section finished?
integer
C4684556 (UMLS CUI [1,1])
C1828479 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Code List
Is data entry for this section finished?
CL Item
Yes (1)
CL Item
No (2)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial